Skip to main content
. 2020 Jan 16;48(1):0300060519898008. doi: 10.1177/0300060519898008

Table 1.

Characteristics of patients with IgAN and depression symptoms at enrollment.

PA group(n = 108) Control group(n = 108) P value
Demographic characteristics
 Age (years) 56.1 ± 10.8 58.1 ± 9.7 0.15
 Female sex (n, %) 67 (62.0%) 63 (58.3%) 0.58
Renal function
 BUN (mmol/L) 56.2 ± 12.1 55.9 ± 13.6 0.86
 Scr (µmol/L) 612.4 ± 102.3 631.9 ± 98.6 0.15
 eGFR (mL/minute/1.73 m2) 34.9 ± 10.3 36.2 ± 11.6 0.38
Pathological staging (n, %)
 IgAN I-III 71 (65.7%) 75 (69.4%) 0.56
 IgAN IV-V 37 (34.3%) 31 (28.7%) 0.38
Clinical records (n, %)
 Smoking 45 (41.7%) 51 (47.2%) 0.41
 Drinking 52 (48.1%) 49 (45.4%) 0.68
 Hypertension 71 (65.7%) 69 (63.9%) 0.78
 Diabetes mellitus 68 (63.0%) 73 (67.6%) 0.48
 Myocardial injury 23 (21.3%) 26 (24.1%) 0.63
 Coronary heart disease 23 (21.3%) 27 (25%) 0.52
 Pulmonary dysfunction 16 (14.8%) 18 (16.7%) 0.71
 Stroke 4 (3.7%) 6 (5.5%) 0.52
 Hemodialysis 38 (35.2%) 42 (38.9%) 0.57

Note: Data are median (interquartile range) or number (%).

Abbreviations: IgAN, IgA nephropathy; PA, physical activity; BUN, blood urea nitrogen; Scr, serum creatinine; eGFR, estimated glomerular filtration rate.